Last reviewed · How we verify
minoxidil 2% solution
At a glance
| Generic name | minoxidil 2% solution |
|---|---|
| Also known as | Rogaine®, Regaine® |
| Sponsor | Allergan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon (PHASE1)
- Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia (PHASE3)
- Bioavailability Clinical Trial of Oral Minoxidil 1 mg (PHASE1)
- Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia (NA)
- Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris (PHASE1, PHASE2)
- Hair Regeneration in Androgenetic Alopecia (NA)
- Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia (PHASE2)
- Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |